Catch Technology, a Taiwan leading image processing SoC and solution provider and DXOMARK, the global authority in image ...
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial ...
Rare diseases are often difficult to diagnose and predicting the best course of treatment can be challenging for clinicians. Investigators from the Mahmood Lab at Brigham and Women's Hospital, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results